MCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, down-regulation of Mcl-1 triggered by Roscovitine analogues would suppress the survival advantage conferred by Mcl-1 in chronic myeloid leukemia, resulting in apoptotic cell death.